Cardiovascular Diabetology (Nov 2011)

Relation between the frequency of CD34<sup>+ </sup>bone marrow derived circulating progenitor cells and the number of diseased coronary arteries in patients with myocardial ischemia and diabetes

  • Bozdag-Turan Ilkay,
  • Turan R Goekmen,
  • Turan C Hakan,
  • Ludovicy Sophie,
  • Akin Ibrahim,
  • Kische Stephan,
  • Arsoy Nicole S,
  • Schneider Henrik,
  • Ortak Jasmin,
  • Rehders Tim,
  • Hermann Tina,
  • Paranskaya Liliya,
  • Kohlschein Peter,
  • Bastian Manuela,
  • Ulus A Tulga,
  • Sahin Kurtulus,
  • Ince Hueseyin,
  • Nienaber Christoph A

DOI
https://doi.org/10.1186/1475-2840-10-107
Journal volume & issue
Vol. 10, no. 1
p. 107

Abstract

Read online

Abstract Background Bone marrow-derived circulating progenitor cells (BM-CPCs) in patients with coronary heart disease are impaired with respect to number and mobilization. However, it is unknown whether the mobilization of BM-CPCs depends on the number of diseased coronary arteries. Therefore, in our study, we analysed the correlation between the diseased coronary arteries and the frequency of CD34/45+ BM-CPCs in peripheral blood (PB) in patients with ischemic heart disease (IHD). Methods The frequency of CD34/45+ BM-CPCs was measured by flow cytometry in 120 patients with coronary 1 vessel (IHD1, n = 40), coronary 2 vessel (IHD2, n = 40), coronary 3 vessel disease (IHD3, n = 40) and in a control group of healthy subjects (n = 40). There was no significant difference of the total number of cardiovascular risk factors between IHD groups, beside diabetes mellitus (DM), which was significantly higher in IHD3 group compared to IHD2 and IHD1 groups. Results The frequency of CD34/45+ BM-CPCs was significantly reduced in patients with IHD compared to the control group (CD34/45+; p +; p +; p = 0.001). But there was no significant difference in frequency of BM-CPCs between the patients with IHD2 and IHD1 (CD34/45+; p = 0.28). In a subgroup we observed a significant negative correlation between levels of hemoglobin AIc (HbAIc) and the frequency of BM-CPCs (CD34/45+; p Conclusions The frequency of CD34/45+ BM-CPCs in PB is impaired in patients with IHD. This impairment may augment with an increased number of diseased coronary arteries. Moreover, the frequency of CD34/45+ BM-CPCs in ischemic tissue is further impaired by diabetes in patients with IHD.

Keywords